Analysis of TCGA (The Cancer Genome Atlas program) data based on the correlation between mRNA expression levels (FPKM values) of TRIM17 and patient survival in breast cancers showed that higher expression of TRIM17 is associated with a better survival probability and that TRIM17 expression could be used as a favorable prognostic indicator in breast cancers [150] (www.proteinatlas.org). This evidence concerns the gene TRIM17 and breast cancer.